These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32798742)

  • 1. Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods.
    Mashel TV; Tarakanchikova YV; Muslimov AR; Zyuzin MV; Timin AS; Lepik KV; Fehse B
    Biomaterials; 2020 Nov; 258():120282. PubMed ID: 32798742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layer-by-Layer technique as a versatile tool for gene delivery applications.
    Linnik DS; Tarakanchikova YV; Zyuzin MV; Lepik KV; Aerts JL; Sukhorukov G; Timin AS
    Expert Opin Drug Deliv; 2021 Aug; 18(8):1047-1066. PubMed ID: 33599154
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.
    Shalaby K; Aouida M; El-Agnaf O
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors.
    Li L; He ZY; Wei XW; Gao GP; Wei YQ
    Hum Gene Ther; 2015 Jul; 26(7):452-62. PubMed ID: 26176432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Synergy between CRISPR and Chemical Engineering.
    Lau CH; Tin C
    Curr Gene Ther; 2019; 19(3):147-171. PubMed ID: 31267870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing.
    Xu Y; Liu R; Dai Z
    Nanoscale; 2020 Oct; 12(41):21001-21014. PubMed ID: 33078813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in CRISPR/Cas9 Delivery Strategies.
    Yip BH
    Biomolecules; 2020 May; 10(6):. PubMed ID: 32486234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein.
    Qiao J; Sun W; Lin S; Jin R; Ma L; Liu Y
    Chem Commun (Camb); 2019 Apr; 55(32):4707-4710. PubMed ID: 30942216
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lau CH; Suh Y
    F1000Res; 2017; 6():2153. PubMed ID: 29333255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.
    Zhang BC; Luo BY; Zou JJ; Wu PY; Jiang JL; Le JQ; Zhao RR; Chen L; Shao JW
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):57362-57372. PubMed ID: 33301289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 20. CRISPR/Cas with ribonucleoprotein complexes and transiently selected telomere vectors allows highly efficient marker-free and multiple genome editing in Botrytis cinerea.
    Leisen T; Bietz F; Werner J; Wegner A; Schaffrath U; Scheuring D; Willmund F; Mosbach A; Scalliet G; Hahn M
    PLoS Pathog; 2020 Aug; 16(8):e1008326. PubMed ID: 32804988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.